For dry powder inhaler formulations, micronized drug powders are commonly mixed with
coarse lactose carriers to facilitate powder handling during the manufacturing and powder …

Inhalation therapy has strong history of more than 4000 years and it is well recognized
around the globe within every culture. In early days, inhalation therapy was designed for …

This paper presents an overview and discussion of magnetocapillary self-assemblies. New
results are presented, in particular concerning the possible development of future …

Although previous research demonstrated improved flowability, packing, fluidization, etc. of
individual powders via nanoparticle dry coating, none considered its impact on very low …

The properties of dry-coated paracetamol particles (fast-dissolving model drug) with
carnauba wax particles as the coating agent (dissolution retardant) were investigated …

Common strategies to improve the dissolution properties of hydrophobic drug compounds
include the preparation of composites with hydrophilic excipients and/or size reduction …

Presently, diverse methods have been well studied for the design and fabrication of versatile
powder and particles. However, these techniques have few limitations on account of the …

This paper considers two fine-sized (d 50∼ 10 µm) model drugs, acetaminophen (mAPAP)
and ibuprofen (Ibu), to examine the effect of API dry coprocessing on their multi-component …

Introduction: Production of functionalised particles using dry powder coating is a one-step,
environmentally friendly process that paves the way for the development of particles with …

Background There is a growing interest in the use of dry powder inhalers (DPIs) for
administering high-dose drugs with low potency to the lungs as carrier-free formulations to …